Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $428 million specializing in mRNA therapeutics and vaccines, stands at a ...
H.C. Wainwright maintained a positive stance on Arcturus Therapeutics (NASDAQ:ARCT) shares, reiterating a Buy rating and a price target of $63. Currently trading at $16.97, the stock has significant ...
While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.
"Browse 243 market data Tables and 43 Figures spread through 233 Pages and in-depth TOC on "Ceramic & Porcelain Tableware Market" The ceramic & porcelain tableware industry continues to grow, driven ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback